AU585280B2 - Sustained-release anabolic implants - Google Patents

Sustained-release anabolic implants

Info

Publication number
AU585280B2
AU585280B2 AU49982/85A AU4998285A AU585280B2 AU 585280 B2 AU585280 B2 AU 585280B2 AU 49982/85 A AU49982/85 A AU 49982/85A AU 4998285 A AU4998285 A AU 4998285A AU 585280 B2 AU585280 B2 AU 585280B2
Authority
AU
Australia
Prior art keywords
anabolic
implants
sustained
release
release anabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49982/85A
Other languages
English (en)
Other versions
AU4998285A (en
Inventor
Jacques Alexandre Cuvelier
Pierre Richard Dr. Dick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRB Virbac SA
Original Assignee
CRB Virbac SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRB Virbac SA filed Critical CRB Virbac SA
Publication of AU4998285A publication Critical patent/AU4998285A/en
Application granted granted Critical
Publication of AU585280B2 publication Critical patent/AU585280B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU49982/85A 1984-11-22 1985-11-18 Sustained-release anabolic implants Ceased AU585280B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8418230A FR2573307B1 (fr) 1984-11-22 1984-11-22 Implants anabolisants a liberation prolongee
FR8418230 1984-11-22

Publications (2)

Publication Number Publication Date
AU4998285A AU4998285A (en) 1986-05-29
AU585280B2 true AU585280B2 (en) 1989-06-15

Family

ID=9310081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49982/85A Ceased AU585280B2 (en) 1984-11-22 1985-11-18 Sustained-release anabolic implants

Country Status (9)

Country Link
AU (1) AU585280B2 (fr)
BE (1) BE903610A (fr)
DE (1) DE3539408A1 (fr)
FR (1) FR2573307B1 (fr)
GB (1) GB2167662B (fr)
IT (1) IT1188195B (fr)
NL (1) NL8503227A (fr)
NZ (1) NZ214179A (fr)
ZA (1) ZA858486B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169894A4 (fr) * 1984-01-31 1986-11-21 Int Found Biochem Endocrino Procede de promotion de la croissance et amelioration de la qualite de la viande des animaux de boucherie avec des hormones steroides femelles.
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
CA2336879C (fr) * 1998-07-20 2010-06-01 Peptech Limited Compositions a liberation prolongee contenant des peptides, des polypeptides, des proteines ou des acides nucleiques comme principes actifs
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US7767708B2 (en) 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
AR025133A1 (es) * 1998-11-04 2002-11-13 Schering Corp Una composicion de implante anabolico para estimular la velocidad aumentada de crecimiento, uso de dicha composicion para la preparacion de un implanteanabolico a un ganado, y metodo para preparar el dispositivo con el implante destinado a la aplicacion animal para estimular el crecimiento
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
PL352250A1 (en) 1999-06-11 2003-08-11 Watson Pharmaceuticals Administration of non-oral androgenic steroids to women
WO2001043748A2 (fr) * 1999-12-16 2001-06-21 Pharmacia & Upjohn Company Composition d'implant contenant de l'acetate de melengestrol et de l'acetate de trenbolone
BR0207052A (pt) 2002-10-15 2004-08-10 Natura Cosmeticos Sa Composição cosmética sólida
US20100144687A1 (en) 2008-12-05 2010-06-10 Glaser Rebecca L Pharmaceutical compositions containing testosterone and an aromatase inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB215137A (en) * 1923-02-23 1924-05-08 Frank Leslie Gridner Improvements in and relating to adjustable chairs
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3920806A (en) * 1973-05-04 1975-11-18 Merck & Co Inc Growth promoting subcutaneous compositions
FR2239988A1 (en) * 1973-08-08 1975-03-07 Aries Robert Animal hormone implants - comprising a mixt. of hormone and fatty acid ester of hormone
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4331652A (en) * 1979-09-12 1982-05-25 Eli Lilly And Company Controlled release parasitic formulations and method
US4333919A (en) * 1979-09-12 1982-06-08 Eli Lilly And Company Growth promotant controlled release formulations and method of treatment

Also Published As

Publication number Publication date
IT1188195B (it) 1988-01-07
NZ214179A (en) 1989-06-28
ZA858486B (en) 1986-06-25
DE3539408A1 (de) 1986-06-05
AU4998285A (en) 1986-05-29
GB2167662B (en) 1988-11-30
GB2167662A (en) 1986-06-04
FR2573307B1 (fr) 1988-06-10
BE903610A (fr) 1986-05-09
NL8503227A (nl) 1986-06-16
IT8522829A0 (it) 1985-11-14
GB8527915D0 (en) 1985-12-18
FR2573307A1 (fr) 1986-05-23

Similar Documents

Publication Publication Date Title
AU591248B2 (en) Sustained-release pharaceutical preparation
AU583762B2 (en) Piperazinyl-heterocyclic compounds
AU614965B2 (en) Thiadiazinones
AU2611588A (en) New phenylethanolamines
AU1407388A (en) Substituted di-t-butylphenols
AU2414288A (en) Polypeptide compounds
AU2222388A (en) Peptidylheterocycles
AU585280B2 (en) Sustained-release anabolic implants
AU1381888A (en) Timeswitches
AU1301788A (en) Chemo-radio-immuno-conjugates
AU2142288A (en) New aluminium-magnesium-hydroxy-compounds
AU1764488A (en) Substituted 5-methylamino-1-arylpyrazoles
AU1309188A (en) New compounds
AU2665388A (en) 17-methylene-and 17-ethylidene-estratrienes
AU587443B2 (en) Sustained-release preparation
AU1148888A (en) New compounds
AU1590788A (en) Leukaemia-inhibitory factor
AU1158888A (en) Scraper-spreader
AU1251788A (en) Feeder
AU1366388A (en) Videosystem
AU2505988A (en) 3-aminopyrazolin-5-ones
AU2698888A (en) Naphthothiazepinones
AU2021888A (en) Sulphonylaminoguanidinoazines
AU2456688A (en) Dripulator
AU2183888A (en) Auto-ejector

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired